| NCT ID | NCT01820325 |
| Title | Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer |
| Recruitment | Terminated |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Novartis|Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult |